CHERESO
CHERESO
 
Any Query?
info@chereso.net
  • Home
  • COMPANY
    • ABOUT US
    • VISION & MISSION
    • AWARDS & ACCREDITATIONS
    • CERTIFICATES
    • SOCIAL RESPONSIBILITY
    • CAREER OPPORTUNITIES
  • ACTIVE INGREDIENTS
  • BRANDED INGREDIENTS
  • MANUFACTURING
    • OUR STATE OF ART FACILITIES
    • QUALITY CONTROL
    • RESEARCH & DEVELOPMENT
  • NEWS & EVENTS
    • NEWS
    • INTERNATIONAL NEWS
    • EVENTS
    • PRESENTATIONS
  • LINKS
  • CONTACT US
  • Home
  • COMPANY
    • ABOUT US
    • VISION & MISSION
    • AWARDS & ACCREDITATIONS
    • CERTIFICATES
    • SOCIAL RESPONSIBILITY
    • CAREER OPPORTUNITIES
  • ACTIVE INGREDIENTS
  • BRANDED INGREDIENTS
  • MANUFACTURING
    • OUR STATE OF ART FACILITIES
    • QUALITY CONTROL
    • RESEARCH & DEVELOPMENT
  • NEWS & EVENTS
    • NEWS
    • INTERNATIONAL NEWS
    • EVENTS
    • PRESENTATIONS
  • LINKS
  • CONTACT US

Presentations

You are here:
  1. Home
  2. Presentations

Fenfuro abstract selected for poster presentation at IDF 2018

Details

Abstract Submission: “Clinical Evaluation Of Standardized Fenugreek Seed Extract As Furostanolic Saponins (Furocyst) In Polycystic Ovary Syndome Patients.”

Details

Abstract Submission: “Clinical Evaluation Fenugreek Seed Extract In Patients With Type-2 Diabetes: An Add-on Study In 154 Patients”

Details

Abstract Submission: Safety, Efficacy And Toxicological Evaluation Of A Novel, Patented Anti-diabetic Extract Of Trigonella Foenum-graecum Seed Extract (Fenfuro)

Details

Abstract submission: “Efficacy of a novel fenugreek seed extract (trigonella foenum-graecum, furocyst) in polycystic ovary syndrome (pcos)”

Details

Abstract submission: ” Safety, efficacy and toxicological evaluation of a novel, patented anti-diabetic extract of trigonella foenum-graecum seed extract (fenfuro).”

Details

Abstract Submission: Safety, efficacy and toxicological evaluation of a novel, patented anti-diabetic extract of Trigonella Foenum-Graecum seed extract (Fenfuro)

Details

Abstract Submission: “Anti-diabetic efficacy of Fenfuro™, a novel, patented Trigonella foenum-graecum seed extract (1019.14)”

Details

Abstract Submission: “Safety, efficacy and toxicological evaluation of a novel, patented anti-diabetic extract of Trigonella Foenum-Graecum seed extract (Fenfuro)”

Details

Abstract Submission: “Efficacy Evaluation Of Fenfuro In Diabetes Type Ii Rat Model.”

Details
12
Next page
QUICK LINKS
Home
About Us
Awards & Accreditations
Vision & Mission
Certificates
Products
Manufacturing
Career Opportunities
NEWSLETTER


DISCLAIMER

Information on this website has been posted in public interest for creating awareness about diabetes/obesity/general health. In event of any copyright conflicts, please inform so that we may take appropriate remedial measures. The products and the claims made on this site have not been evaluated by FDA and are not approved to diagnose, treat, cure or prevent diseases.

WE SUPPORT
Copyright @ 2014 - Chemical Resources

Site by SWS